SCHEMBL14511497

SCHEMBL14511497

O=S(=O)(O)c1ccccc1NI

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 2/20 0.46
▸ FABP4 P15090 1/20 0.46
▸ CCNA2 P20248 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ MAPK14 Q16539 1/20 0.46
▸ NR4A1 P22736 1/20 0.45
▸ CA2 P00918 7/20 0.41
▸ CA1 P00915 6/20 0.41
▸ CA9 Q16790 2/20 0.41
▸ CA12 O43570 1/20 0.41
▸ CA6 P23280 1/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA5B Q9Y2D0 1/20 0.41
▸ MYC P01106 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CHAT P28329 1/20 0.39
▸ SNCA P37840 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3244193 0.80 TTR (0.55) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL8779847 0.80 TTR (0.47) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL6911279 0.79 TTR (0.64) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL5403732 0.78 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL7513876 0.78 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL31504547 0.78 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL998621 0.78 CA2 (0.67) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL3379116 0.78 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL7514455 0.78 TTR (0.46) TTRFABP4CCNA2CDK2MAPK14
SCHEMBL35949 0.78 HTR6 (0.60) TTRFABP4CCNA2CDK2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1381590-B1 3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR LIGANDS SCHERING CORP (US) 2007-06-20 — — EP disclosed
Send feedback